While Hinsdale's policy carves out time for cell phone use, Gov. Pritzker's state-wide proposal bans them for the entire school day. Though, there are exceptions, most notably during lunchtime and ...

Study finds SuperAgers in their 80s and 90s produce twice as many young neurons as healthy adults and 2.5 times more than people with Alzheimer's.

Whether it's their reliance on technology or a decline in critical thinking skills, here are 11 reasons Gen Z is less intelligent than any previous generation, according to research.

In a corner of North Las Vegas where sirens and flashing lights are a regular soundtrack, adults in mental health or substance use crisis now have somewhere else to go besides an emergency room or a ...

A relative unknown, if you don’t watch the biotherapeutics industry, Iovance Biotherapeutics (NASDAQ:IOVA) surged 43% in the ...

The 180-day warning period for the Hands-Free Law is coming to an end. Beginning February 28, 2026, drivers can be issued ...

A 91-year-old man with a history of bladder carcinoma and left total knee arthroplasty was evaluated because of left knee pain. A culture of synovial fluid showed no growth. A diagnosis was made.

A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the ...

The federal government is awarding up to $144 million in contracts to several universities and other research teams to study age-related illnesses and healthy longevity.

CareDx expects full year 2026 revenue of $420 million to $444 million. Testing Services revenue is projected at $306 million to $326 million, with total testing volume of 220,000 to 228,000 tests. The ...

How do plants achieve their remarkably regular arrangement of leaves and flowers? And why does this pattern remain so stable, even as plants grow and respond to their environment? Researchers at ...

Fulcrum Therapeutics, Inc. ( FULC) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST Good morning, and welcome to the Fulcrum Therapeutics conference call to discuss 12-week data from the ...